Quarterly report pursuant to Section 13 or 15(d)

Equity-based Compensation - Stock Options (Details)

v3.22.2.2
Equity-based Compensation - Stock Options (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Number of Options    
Beginning balance (in shares) 507,479 273,026
Granted (in shares) 234,453  
Exercised (in shares) 0  
Forfeited/Repurchased (in shares) 0  
Ending balance (in shares) 507,479 273,026
Ending balance, Vested (in shares) 73,603  
Weighted Average Exercise Price    
Beginning balance (in dollars per share) $ 9.50  
Granted (in dollars per share) 3.97  
Exercised (in dollars per share) $ 0  
Forfeited/Repurchased (in dollars per share) 0  
Ending balance (in dollars per share) $ 6.95 $ 9.50
Weighted Average Remaining Contractual Term 9 years 3 months 14 days 9 years 8 months 23 days
Vested, Weighted Average Remaining Contractual Term 8 years 11 months 23 days  
Aggregate Intrinsic Value $ 0 $ 0